Glen Santangelo
Stock Analyst at Jefferies
(2.38)
# 3,037
Out of 4,883 analysts
76
Total ratings
46.81%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Hold | $10 → $8 | $8.35 | -4.19% | 7 | Apr 21, 2025 | |
| ANIP ANI Pharmaceuticals | Initiates: Buy | $80 | $65.26 | +22.60% | 1 | Mar 14, 2025 | |
| VTRS Viatris | Maintains: Buy | $15 → $13 | $9.34 | +39.19% | 4 | Mar 7, 2025 | |
| WAY Waystar Holding | Initiates: Buy | $51 | $38.67 | +31.89% | 1 | Feb 11, 2025 | |
| XERS Xeris Biopharma Holdings | Reiterates: Buy | $4 → $6 | $4.73 | +26.85% | 2 | Jan 29, 2025 | |
| NVST Envista Holdings | Maintains: Hold | $20 → $22 | $20.17 | +9.07% | 1 | Jan 23, 2025 | |
| XRAY DENTSPLY SIRONA | Downgrades: Hold | $30 → $20 | $16.57 | +20.70% | 2 | Jan 23, 2025 | |
| PCRX Pacira BioSciences | Maintains: Buy | $15 → $18 | $23.22 | -22.46% | 5 | Sep 24, 2024 | |
| PGNY Progyny | Maintains: Buy | $31 → $24 | $21.24 | +12.99% | 4 | Sep 19, 2024 | |
| HIMS Hims & Hers Health | Maintains: Hold | $14 → $23 | $47.46 | -51.54% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $23 | $17.05 | +34.90% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $41 → $44 | $30.51 | +44.22% | 3 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $14.72 | +15.49% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $230 | $159.08 | +44.58% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.65 | +1,442.50% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $70 | $23.58 | +196.86% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $7.47 | +636.77% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $8.91 | +79.57% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $14 | $4.05 | +245.68% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $46 | $59.31 | -22.44% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $80 | $101.28 | -21.01% | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $4.06 | +590.51% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $29.08 | +140.72% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $8.59 | +1,296.97% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2 | $2.63 | -23.95% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $5.06 | +829.77% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $4.03 | +793.30% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $66.60 | - | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $173 → $169 | $705.45 | -76.04% | 5 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $161.98 | - | 4 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $82 | $74.48 | +10.10% | 2 | Apr 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $196.98 | +26.92% | 1 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $78 | $11.49 | +578.85% | 1 | Dec 4, 2017 |
Teladoc Health
Apr 21, 2025
Maintains: Hold
Price Target: $10 → $8
Current: $8.35
Upside: -4.19%
ANI Pharmaceuticals
Mar 14, 2025
Initiates: Buy
Price Target: $80
Current: $65.26
Upside: +22.60%
Viatris
Mar 7, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $9.34
Upside: +39.19%
Waystar Holding
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $38.67
Upside: +31.89%
Xeris Biopharma Holdings
Jan 29, 2025
Reiterates: Buy
Price Target: $4 → $6
Current: $4.73
Upside: +26.85%
Envista Holdings
Jan 23, 2025
Maintains: Hold
Price Target: $20 → $22
Current: $20.17
Upside: +9.07%
DENTSPLY SIRONA
Jan 23, 2025
Downgrades: Hold
Price Target: $30 → $20
Current: $16.57
Upside: +20.70%
Pacira BioSciences
Sep 24, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $23.22
Upside: -22.46%
Progyny
Sep 19, 2024
Maintains: Buy
Price Target: $31 → $24
Current: $21.24
Upside: +12.99%
Hims & Hers Health
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $47.46
Upside: -51.54%
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $17.05
Upside: +34.90%
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $30.51
Upside: +44.22%
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $14.72
Upside: +15.49%
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $159.08
Upside: +44.58%
Dec 15, 2023
Reiterates: Buy
Price Target: $10
Current: $0.65
Upside: +1,442.50%
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $23.58
Upside: +196.86%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $7.47
Upside: +636.77%
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $8.91
Upside: +79.57%
Oct 21, 2022
Assumes: Buy
Price Target: $14
Current: $4.05
Upside: +245.68%
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $59.31
Upside: -22.44%
Mar 28, 2022
Maintains: Buy
Price Target: $62 → $80
Current: $101.28
Upside: -21.01%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $4.06
Upside: +590.51%
Dec 2, 2021
Initiates: Buy
Price Target: $70
Current: $29.08
Upside: +140.72%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $8.59
Upside: +1,296.97%
Dec 2, 2021
Initiates: Hold
Price Target: $2
Current: $2.63
Upside: -23.95%
Dec 2, 2021
Initiates: Buy
Price Target: $47
Current: $5.06
Upside: +829.77%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $4.03
Upside: +793.30%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $66.60
Upside: -
May 21, 2020
Maintains: Hold
Price Target: $173 → $169
Current: $705.45
Upside: -76.04%
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $161.98
Upside: -
Apr 24, 2018
Maintains: Buy
Price Target: $79 → $82
Current: $74.48
Upside: +10.10%
Dec 8, 2017
Initiates: Hold
Price Target: $250
Current: $196.98
Upside: +26.92%
Dec 4, 2017
Initiates: Hold
Price Target: $78
Current: $11.49
Upside: +578.85%